摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,3S,10R,11R)-silybin | 891827-72-8

中文名称
——
中文别名
——
英文名称
(2R,3S,10R,11R)-silybin
英文别名
2,3-cis-silybin A;(2R,3S)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one
(2R,3S,10R,11R)-silybin化学式
CAS
891827-72-8
化学式
C25H22O10
mdl
——
分子量
482.444
InChiKey
SEBFKMXJBCUCAI-KMRPREKFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.36
  • 重原子数:
    35.0
  • 可旋转键数:
    4.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    155.14
  • 氢给体数:
    5.0
  • 氢受体数:
    10.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    水飞蓟宾三氟化硼乙醚 作用下, 以 乙醚甲基叔丁基醚N,N-二甲基甲酰胺正丁醇 为溶剂, 反应 149.0h, 生成 (2R,3S,10R,11R)-silybin
    参考文献:
    名称:
    cistrans Isomerization of silybins A and B
    摘要:
    方法已经开发和优化,用Lewis酸催化(BF3∙OEt2)对硅基素丙素A (1a)和B (1b)(式异构体)进行异构化,制备2,3-cis和10,11-cis异构体。所有光学纯化合物的绝对构型通过使用NMR和将它们的电子圆二色性数据与已知绝对构型的模型化合物进行比较来确定。提出了硅基素丙素cistrans异构化的机理,并得到了量子力学计算的支持。
    DOI:
    10.3762/bjoc.10.105
点击查看最新优质反应信息

文献信息

  • Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
    申请人:UNIVERSITY OF KANSAS
    公开号:US10702568B2
    公开(公告)日:2020-07-07
    Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described. The compositions and methods are useful in reducing appearance of facial redness in rosacea-prone skin, rejuvenating skin, preventing skin aging, inhibiting oxidative stress in epidermal and dermal cells, increasing collagen production, reducing the likelihood of skin cancer, treating or reducing liver damage from a toxin, or treating a liver disease.
    描述了含有水飞蓟素和磺烷基醚环糊精,特别是磺丁基醚环糊精的化妆品和膳食补充剂组合物。这些组合物和方法可用于减少易患红斑痤疮的皮肤出现面部发红、嫩肤、防止皮肤老化、抑制表皮和真皮细胞中的氧化应激、增加胶原蛋白的生成、减少皮肤癌的可能性、治疗或减少毒素对肝脏的损害或治疗肝病。
  • COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME
    申请人:CyDex Pharmaceuticals, Inc.
    公开号:US20180133274A1
    公开(公告)日:2018-05-17
    Cosmetic and dietary supplement compositions containing silymarin and sulfoalkyl ether cyclodextrin, particularly sulfobutyl ether cyclodextrin, are described. The compositions and methods are useful in reducing appearance of facial redness in rosacea-prone skin, rejuvenating skin, preventing skin aging, inhibiting oxidative stress in epidermal and dermal cells, increasing collagen production, reducing the likelihood of skin cancer, treating or reducing liver damage from a toxin, or treating a liver disease.
  • <i>cis</i>–<i>trans</i> Isomerization of silybins A and B
    作者:Michaela Novotná、Radek Gažák、David Biedermann、Florent Di Meo、Petr Marhol、Marek Kuzma、Lucie Bednárová、Kateřina Fuksová、Patrick Trouillas、Vladimír Křen
    DOI:10.3762/bjoc.10.105
    日期:——

    Methods were developed and optimized for the preparation of the 2,3-cis- and the 10,11-cis-isomers of silybin by the Lewis acid catalyzed (BF3∙OEt2) isomerization of silybins A (1a) and B (1b) (trans-isomers). The absolute configuration of all optically pure compounds was determined by using NMR and comparing their electronic circular dichroism data with model compounds of known absolute configurations. Mechanisms for cistrans-isomerization of silybin are proposed and supported by quantum mechanical calculations.

    方法已经开发和优化,用Lewis酸催化(BF3∙OEt2)对硅基素丙素A (1a)和B (1b)(式异构体)进行异构化,制备2,3-cis和10,11-cis异构体。所有光学纯化合物的绝对构型通过使用NMR和将它们的电子圆二色性数据与已知绝对构型的模型化合物进行比较来确定。提出了硅基素丙素cistrans异构化的机理,并得到了量子力学计算的支持。
查看更多

同类化合物

红景天灵 水飞蓟素B2 水飞蓟素A,B 水飞蓟宾磷脂酰胆碱(SPC) 水飞蓟宾 水飞蓟宾 水飞木质灵 次大风子素 异水飞蓟宾B 亚聚丙基二醇,甲苯二异氰酸酯,羟基丙基甲丙烯酰酸酯聚合物 4-[(2R)-5,7-二羟基-2-[(2R)-2-(4-羟基-3-甲氧基苯基)-3-[(4-羟基-4-氧代丁酰基)氧基甲基]-2,3-二氢-1,4-苯并二氧杂环己-7-基]-4-氧代色满-3-基]氧基-4-氧代丁酸 3,7-二羟基-2-(1,4-苯并二恶烷-6-基)色满-4-酮 3,7-二羟基-2-((2,3-二苯基)-1,4-苯并二恶烷-6-基)色满-4-酮 2,3-脱氢水飞蓟宾B 2,3-脱氢水飞蓟宾A 3,4-methylene-dioxybenzoic acid mono[[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-6-(2,3-dihydro-3,5,7-trihydroxy-4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-yl]methyl] ester 5'-methoxyhydnocarpin-D 5'-methoxyhydnocarpin sinaicitin-D Silybin 23-O-β-lactoside 3,4-dimethoxybenzoic acid mono[[2,3-dihydro-3-(4-hydroxy-3-methoxy phenyl)-6-(2,3-dihydro-3,5,7-trihydroxy-4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-yl]methyl] ester 3,5-dinitrobenzoic acid mono[[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-6-(2,3-dihydro-3,5,7-trihydroxy-4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-yl]methyl] ester 3-chlorobenzoic acid mono[[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-6-(2,3-dihydro-3,5,7-trihydroxy-4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-yl]methyl] ester sodium silybin-23-O-(4-nitrophenyl)-phosphate 23-chloro-2,3-dehydrosilybin 5,7,20-O-trimethyl-2,3-dehydrosilybin 1,3,11a-trihydroxy-9-(3,5,7-trihydroxy-4H-1-benzopyran-4-on-2-yl)-5a-(3,4-dihydroxyphenyl)-5,6,11-hexahydro-5,6,11-trioxanaphthacene-12-one (+/-)-sinaiticin (10S,11S)-hydnocarpin D (2R,3R,10S,11R)-silybin silybin B 20-O-sulfate (2R,3S,10S,11S)-silybin silybin A 20-O-sulfate (2R,3S,10R,11R)-silybin (2SR*,2'R*,3'R*)-2-<2-(4-Benzyloxy-3-methoxyphenyl)-3-hydroxymethyl-1,4-benzodioxan-6-yl>-2,3-dihydro-5,7-dihydroxy-4H-benzopyran-4-one hydnocarpin-D peracetate hydnocarpin (+/-)-5'-methoxyhydnocarpin-D 5-deoxy-3-hydroxyhydnocarpin-D 3-O-pentyl-2,3-dehydrosilibinin 7-O-dihydroferuloylsilibinin silymarin Legalon SIL disodium;(2R,3R)-3-(3-carboxypropanoyloxy)-2-[(2R,3R)-2-(3-carboxypropanoyloxymethyl)-3-(3-methoxy-4-oxidophenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-7-hydroxy-4-oxo-2,3-dihydrochromen-5-olate 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5-dihydroxy-7-(cis,cis-9,12-octadecadienoyl)-oxy-4H-1-benzopyran-4-one 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-((cis,cis-9,12-octadecadienoyl)-oxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one 2-(2,3-dihydro-benzo[1,4]dioxan-6-yl)-3-hydroxy-7-benzyloxy-benzopyran-4-one 6,8-Dichloro-2-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-chromen-4-one 7-Chloro-2-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-chroman-4-one 2-<2-2-(N1,N1-Diethylaminoethyl)carboxamido>-1,4-benzodioxane-7-yl>-4H-1-benzopyran-4-one